2026 National Rare Hematology Summit, Cleveland
Accreditation: 9.00 Nursing Contact Hours | 9.00 ABIM MOC II | 9.00 AMA PRA Category 1 Credit™ | 9.00 ACPE Pharmacy
Venue: Crowne Plaza Cleveland at Playhouse Square, 1260 Euclid Avenue, Cleveland, OH, 44115, United States
Official conference page for 2026 National Rare Hematology Summit, Cleveland. https://binaytara.org/projects/conferences/2026-national-rare-hematology-summit-cleveland
About 2026 National Rare Hematology Summit, Cleveland


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Day 1: Friday, August 7th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Uma M Borate, MD; Abhay Singh, MD, MPH
02:05 PM - 02:20 PM
Pathogenesis and Risk Stratification – Zoey Xie, MD, MS
02:20 PM - 02:35 PM
Relationship with Hematologic Malignancies and Cardiovascular Disease – Ohad Oren, MD, MPH
02:35 PM - 02:50 PM
Clinical Monitoring and Management Strategies – Namrata Chandhok, MD
02:50 PM - 03:05 PM
Panel Discussion
Moderators:
Abhay Singh, MD, MPH; Uma M Borate, MD
Panelists:
Zoey Xie, MD, MS; Ohad Oren, MD, MPH; Namrata Chandhok, MD
Session Chair: Gordon Srkalovic, MD
03:45 PM - 03:55 PM
Classification and Diagnostic Criteria – Joshua Daniel Brandstadter, MD, PhD, MSc
03:55 PM - 04:05 PM
KSHV/HHV8+ MCD vs Idiopathic Castleman Disease – Kathryn Lurain, MD, MPH
04:05 PM - 04:15 PM
Emerging Treatment Options and Ongoing Trials – Sudipto Mukherjee, MD, PhD, MPH
04:15 PM - 04:20 PM
Case Presentation – Rafaella Litvin, MD
04:20 PM - 04:45 PM
Case-Based Discussion
Moderators:
Gordon Srkalovic, MD
Panelists:
Joshua Daniel Brandstadter, MD, PhD, MSc; Kathryn Lurain, MD, MPH; Sudipto Mukherjee, MD, PhD, MPH
Session Chair: Daniel J. DeAngelo, MD, PhD
04:45 PM - 05:00 PM
Molecular Profiling and Diagnostic Advances – David Bosler, MD
05:00 PM - 05:15 PM
Management of HES – Princess Ogbogu, MD
05:15 PM - 05:30 PM
Therapies in Indolent and Aggressive Mastocytosis – Pankit J Vachhani, MD
05:30 PM - 05:35 PM
Case Presentation – Akriti G Jain, MD
05:35 PM - 06:00 PM
Case-Based Discussion
Moderators:
Daniel J. DeAngelo, MD, PhD
Panelists:
Princess Ogbogu, MD; David Bosler, MD; Pankit J Vachhani, MD
Day 2: Saturday, August 8th, 2026
Session Chair: Deepa Jagadeesh, MD
08:20 AM - 08:35 AM
Peripheral T-Cell Lymphoma Variants – Yumeng Zhang, MD
08:35 AM - 08:50 AM
NK/T-Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma – Deepa Jagadeesh, MD
08:50 AM - 09:05 AM
Targeted Therapy and Clinical Trials Landscape – Taylor Brooks, MD
09:05 AM - 09:20 AM
Panel Discussion
Moderators:
Deepa Jagadeesh, MD
Panelists:
Yumeng Zhang, MD; Taylor Brooks, MD
Session Chair: Rakhi Naik, MD
09:20 AM - 09:40 AM
Von Willebrand Disease: Diagnosis and Management Pearls – Rakhi Naik, MD
09:40 AM - 10:00 AM
Hemophilia-2026 Update – Bernard Silver, MD
10:00 AM - 10:20 AM
Case-Based Discussion
Moderators:
Rakhi Naik, MD
Panelists:
Bernard Silver, MD
Session Chair: Daniella Schwartz, MD
11:05 AM - 11:15 AM
Diagnosis and Management of Macrophage Activating Syndrome – Casandra Calabrese, DO
11:15 AM - 11:25 AM
HLH in Malignancy and Infections – Sudipto Mukherjee, MD, PhD, MPH
11:25 AM - 11:30 AM
Case Presentation – Kirti Arora, MD
11:30 AM - 11:50 AM
Case-Based Discussion
Moderators:
Daniella Schwartz, MD
Panelists:
Casandra Calabrese, DO; Sudipto Mukherjee, MD, PhD, MPH; Kirti Arora, MD
